×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Destiny Pharma Issues New Shares, Expands Capital - TipRanks.com
Tipranks
Destiny Pharma plc (GB:DEST) has released an update. Destiny Pharma plc, a clinical-stage biotech company, has announced the issuance of 200000 new ordinary...
16 minutes ago
Destiny ends COVID collab, Santhera returns lonodelestat
Fierce Biotech
Both Destiny Pharma and Santhera Pharmaceuticals used their earnings announcements this morning to explain why a tighter clinical focus will...
1 month ago
Investors in Destiny Pharma (LON:DEST) have unfortunately lost 43% over the last five years
Yahoo Lifestyle Canada
Destiny Pharma plc ( LON:DEST ) shareholders will doubtless be very grateful to see the share price up 83% in the last...
2 weeks ago
We're Hopeful That Destiny Pharma (LON:DEST) Will Use Its Cash Wisely
Simply Wall Street
While Destiny Pharma does have a solid cash runway, its cash burn trajectory may have some shareholders thinking ahead to when the company may...
4 months ago
Destiny Pharma assessing options for XF-73 nasal | AIM:DEST, OTC:DTTYF
Proactive Investors
Destiny Pharma PLC (AIM:DEST, OTC:DTTYF) said it is exploring 'strategic options' to advance the development of XF-73 nasal, a breakthrough...
1 month ago
Destiny Pharma reports progress on clinical assets
Sharecast.com
Clinical-stage biotechnology company Destiny Pharma said in a year-end update on Thursday that its primary focus remained on realising the...
4 months ago
The Business Magazine article image for: Brighton's Destiny Pharma posts encouraging interim results
The Business Magazine
Brighton-based clinical stage biotechnology company Destiny Pharma has posted its interim results for the six months ended 30 June 2023.
8 months ago
Destiny Pharma Announces AGM and Report Availability
TipRanks
Destiny Pharma (GB:DEST) has released an update. Destiny Pharma, a clinical-stage biotechnology firm, has made its Annual Report for 2023...
2 weeks ago
Destiny Pharma reports strong FY23 performance, explores options for XF-73 Phase 3 trials
Vox Markets
Destiny Pharma unveils robust 2023 financial results and initiates a strategic review to optimise the progression of its XF-73 Nasal...
1 month ago
SMALL CAPS IDEA: Destiny Pharma playing its part in the race to diffuse deadly $1trillion healthcare timebomb
This is Money
SMALL CAPS IDEA: Destiny Pharma is playing its part in the race to diffuse a deadly $1trillion healthcare timebomb with two phase III-ready...
4 months ago